NIACINAMIDE 4% / TAZAROTENE 0.1%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-04-23
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:25
Label at a glance#
ProductNIACINAMIDE 4% / TAZAROTENE 0.1%
Active ingredientTAZAROTENE, NIACINAMIDE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions.
Active Inactive
NDC 72934-2061-2 NIACINAMIDE 4 / TAZAROTENE 0.01 Cream 30gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| TAZAROTENE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a107c35c-2cb4-4734-a92b-e9ed5cfc34d6 | Product name | 2 | 20260220 |
| 5993ea1b-833d-fa4b-caad-a0d477537538 | Product name | 5 | 20250305 |
| c24b0f4e-b27e-8e2b-a129-1b5a6d72c459 | Product name | 2 | 20231128 |
| 18da2240-e326-4d63-90cd-d6bb15f662a0 | Product name | 1 | 20200604 |
| a32b252c-8cd2-cc4a-c64c-4b9d3916df9e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-2161-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1cc1-a910-e053-dadaa90a0b85 | NIACINAMIDE 4% / TAZAROTENE 0.1% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-2161-2 | NIACINAMIDE 4% / TAZAROTENE 0.1% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-2161 | NIACINAMIDE 4% / TAZAROTENE 0.1% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190501_8738c9c8-17b1-b7b7-e053-2a91aa0acdfb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-2161-2 | GM - Gram | 72934-2161 | fbc9330e-f340-4764-bde3-ead7c3c01b2c | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- NIACINAMIDE 4% / TAZAROTENE 0.1%
- TAZAROTENE
- NIACINAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-2161 | 72934-2161-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TAZAROTENE | 81BDR9Y8PS | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8738c9c8-17b2-b7b7-e053-2a91aa0acdfb | 8738c9c8-17b1-b7b7-e053-2a91aa0acdfb | 2019-04-23 | Adverse reactions | 8738c9c8-17b2-b7b7-e053-2a91aa0acdfb 8738c9c8-17b1-b7b7-e053-2a91aa0acdfb |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


